Letter: Alpha-receptor-blocking drugs in bronchial asthma.
D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000627:therapeutic use*; D000402:Airway Obstruction / Q000188:drug therapy; D000403:Airway Resistance / Q000187:drug effects; D000420:Albuterol / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D004338:Drug Combinations; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D013948:Moxisylyte / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D012138:Respiratory Therapy
D000317:Adrenergic alpha-Antagonists; D000318:Adrenergic beta-Agonists; D004338:Drug Combinations; D007545:Isoproterenol; D013948:Moxisylyte; D000420:Albuterol; D010646:Phentolamine